Table 1.
Clinico-pathological characteristics of the patients.
| Variable | HPV+ HNSCC | CESC | ||
|---|---|---|---|---|
| No. | % | No. | % | |
| Total No. of Patients | 62 | 71 | ||
| Age | ||||
| Median | 57 | 51 | ||
| Range | 41–77 | 26–77 | ||
| Stage | ||||
| I | 46 | 74.2 | 57 | 80.3 |
| II | 13 | 21.0 | 8 | 11.3 |
| III–IV | 3 | 4.8 | 6 | 8.6 |
| Therapy | ||||
| Radiotherapy | 62 | 100 | 15 | 21.1 |
| Chemotherapy | 21 | 33.9 | 15 | 21.1 |
| HPV subtype | ||||
| 16 | 57 | 91.9 | 50 | 70.4 |
| 18 | 1 | 1.6 | 5 | 7 |
| 33 | 1 | 1.6 | 5 | 7 |
| 35 | 3 | 4.9 | 0 | 0 |
| 45 | 0 | 0 | 4 | 5.6 |
| Other (31, 58, 59, 70, 73) | 0 | 0 | 7 | 10 |
| Co-infection | 1 | 1.6 | 9 | 12.7 |
| Outcome | ||||
| Relapse | 6 | 9.7 | 7 | 9.9 |
| Exitus | 12 | 19.4 | 7 | 9.9 |
| Smoking history | ||||
| Smoker | 15 | 24.2 | 30 | 42.6 |
| Ex-smoker | 23 | 37.1 | NA | NA |
| Non-smoker | 24 | 38.7 | 40 | 55.9 |
| NA | 0 | 0 | 1 | 1.5 |